| Temporary ex vivo inhibition of the expression of the human oncogene HER2 (NEU) by a triple helix-forming oligonucleotide. | None |
| [Expression of the c-erbB-2 oncoprotein in mammary Paget s disease. Immunohistochemical study by using 3 antibodies]. | None |
| Amplification and expression of the c-erbB-2 oncogene in normal, hyperplastic, and malignant endometria. | None |
| Evaluation of HER-2/neu (c-erbB-2) oncogene expression in whole organ sections of supraglottic squamous cell carcinoma. | None |
| Quantitative analyses of epidermal growth factor receptors, HER-2/neu oncoprotein and cathepsin D in nonmalignant and malignant uteri. | None |
| Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-protein. | None |
| Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation. | None |
| Expression of c-erbB2 oncogene product in different tumours and its standardised evaluation. | None |
| Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines. | None |
| [Advances in the study of proto-oncogene c-erbB-2]. | None |
| [Relationship between c-erbB-2 oncoprotein expression and prognosis in salivary gland malignant pleomorphic adenoma]. | None |
| Expression of the erbB-2 proto-oncogene during differentiation of the mammary gland in the rat. | None |
| The role of the HER-2/neu oncogene in gynecologic cancers. | None |
| Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice. | None |
| c-neu oncoprotein in developing rostral cerebral cortex: relationship to epidermal growth factor receptor. | None |
| [Immunohistological study on proliferative activities and expression of c-erbB-2 oncoprotein in salivary gland tumors]. | None |
| Autoantibody to p185erbB2/neu oncoprotein by vaccination with xenogenic DNA. | None |
| Serum levels of the c-erbB-2 (HER2/neu) encoded oncoprotein fragment p105 in normal pregnancies. | None |
| The erbB 2 oncogene and chemotherapy: a mini-review. | None |
| Costimulation of T cell proliferation by a chimeric B7-2 antibody fusion protein specifically targeted to cells expressing the erbB2 proto-oncogene. | None |